N-termiznal probrain natriuretic peptide predicts adverse outcomes in acute myocardial infarction even with preserved left ventricular ejection fraction

Indian Heart Journal

Volumn 58, Issue 2, 2006, Pages 138-143

  Puri, Aniket ^a,b   Narain, Varun S ^a   Mehrotra, Sanjay ^a   Dwivedi, Sudhanshu K ^a   Saran, Ram K ^a   Puri, Vijay K ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b B 58 ^*  (India)

Author keywords

Acute myocardial infarction; Ejection fraction; N terminal probrain natriuretic peptide

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; RECURRENT DISEASE; SCORING SYSTEM; BLOOD; ECHOGRAPHY; HEART INFARCTION; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; RISK ASSESSMENT;

AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 33749548485     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type Natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-67.
2. de Lemos JA, Morrow DA. Brain natriuretic peptide measurement in acute coronary syndromes: ready for clinical application? Circulation 2002;106:2868-70.
3. Richards AM, Nicholls MG, Yandle TG, et al. Plasma N-terminal pro-brain Natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-29.
4. Puri A, Narain VS, Dwivedi SK, Saran RK, Puri VK. N terminal pro brain natriuretic peptide (NT ProBNP) as a predictor of short-term outcomes in acute myocardial infarction. Indian Heart J 2005;57:304-10.
5. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary. J Am Coll Cardiol 2004;44:671-719.
6. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment : an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000;102:2031-37.
7. Jacobs DR Jr, Kroenke C, Crow R, et al. PREDICT: a simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota Heart Survey. Circulation 1999;100:599-607.
8. Talwar S, Squire IB, Downie PF, et al. Profile of plasma N-terminal ProBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction. Eur Heart J 2000;21:1514-21.
9. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002; 40:976-82.
10. Nakao K, Mukoyama M, Hosoda K, et al. Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide. Canad J Physiol Pharmacol 1991;69:1500-06.
11. Pan J, Fukuda K, Saito M, et al. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circulation Res 1999;84:1127-36.
12. Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation 1996;3:1963-69.
13. Arakawa N, Nakamura M, Aoki H, Moriai N, Suzuki T, Hiramori K. Plasma brain natriuretic peptide predicts survival after acute myocardial infarction. J Am Coll Cardiol 1996;27:1656-61.
14. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-21.
15. Omland T, Persson A, Ng L, et al. N-terminal Pro-B-type natriuretic peptide and long term mortality in acute coronary syndromes. Circulation 2002;106:2913-18.
16. Galvani M, Ottani F, Murena E, et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of ACS. J Am Coll Cardiol 2003;41:402.
17. Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA. Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail 2004;6:289-93.
18. Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type Natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction. B-type Natriuretic peptide and prognosis in TACTICS-TIMI 18 trial. J Am Coll Cardiol 2003;41:1264-72.
19. Suzuki S, Yoshimura M, Nakayama M, et al. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction. Circulation 2004;110:1387-91.
20. Galvani M, Ferrini D, Ottani F. Natriuretic peptides for risk stratification of patients with acute coronary syndromes. Eur J Heart Fail 2004;6:327-33.
21. Jernberg T, Stridsberg M, Venge P, Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002;40:437-45.
22. James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a global utilization of strategies to open occluded arteries (GUSTO)-IV substudy. Circulation 2003;108:275-81.
23. Talwar S, Squire IB, Downie PF. Plasma N-terminal pro-brain natriuretic peptide and cardiotrophin-1 are raised in unstable angina. Heart 2000;84:421-24.
24. Bazzinoa O, Fusellib JJ, Bottoc F, de Arenazaa DP, Bahita C, Dadoned J. Relative value of N-terminal probrain Natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST elevation acute coronary syndromes for the PACS group of investigators. Eur Heart J 2004;25:859-866.
25. Zeller M, Cottin Y, Laurent Y, et al. N-terminal proBNP in patients of non-ST-elevation myocardial infarction. Cardiology 2004;102:37-40.
26. Galvani M, Ottani F, Oltrona L, et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation 2004;110:128-34.
27. Richards AM, Nicholls MG, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-29.
28. Omland T, de Lemos JA, Morrow DA, Antman EM, Cannon CP, Hall CEB. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in acute coronary syndromes. Am J Cardiol 2002;89:463-65.
29. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide: a new marker of cardiac impairment. Clin Endocrinol 1997;47:287-96.
30. Tschope C, Kasner M, Westermann D, Gaub R, Poller WC, Schultheiss HP. The role of NT ProBNP in the diagnosis of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J 2005;26:2277-84.
31. Bassan R, Potch A, Maisel A, et al. B-type natriuretic peptide: a novel early marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 2005;26:234-40.
32. Stewart RAH. Broader indications for B-type natriuretic peptide testing in coronary artery disease. Eur Heart J 2005;26:207-09.
33. Mehta RH. Perspective on N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. ACC Curr J Rev 2004;13(10):10.
34. Cleland JC, Goode K. Natriuretic peptides. Fashionable? Useful? Necessary? Eur J Heart Fail 2004;6:253-55.
35. Blom JR, van't Hof AWJ, Henriques JPS, Geertman JH, Slingerland R, Hoorntje JCA. NT-ProBNP: a marker for successful myocardial reperfusion in AMI patients treated with primary percutaneous coronary intervention. Eur J Heart Fail 2004;6:749-52.